Anaptysbio, Inc. · NASDAQ:ANAB
The Vanguard Group reported a 5.23% stake in Anaptysbio, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Jul 29, 2025
The Vanguard Group reported a 5.23% stake in Anaptysbio, Inc., 1,537,550 shares, as a passive investor on Jun 30, 2025. Filed Jul 29, 2025 (Schedule 13G).
- Stake
- 5.23%
- Shares
- 1,537,550
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.23% | 1,537,550 |
Source
Related
- Anaptysbio, Inc.
- The Vanguard Group
- Anaptysbio, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Schedule 13G/A · The Vanguard Group · Apr 30, 2025
- Form 4 · Renton Hollings · Oct 2, 2026
- Form 4 · Orwin John A · Sep 17, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Form 4 · Schmid John P. · Jun 17, 2026
- Form 4 · Renton Hollings · Jun 17, 2026